MetaCap

BlossomHill Therapeutics Statistics

NASDAQ: BLSMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

14.51+0.10 (+0.69%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BlossomHill Therapeutics by the numbers

BlossomHill Therapeutics has a market capitalization of $461.2 million based on 31.78M shares outstanding. With trailing EPS of $-10.38, BlossomHill Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.0% below its 50-day average and 17.5% below its 200-day average.

Average daily trading volume is 193.15K shares, or about $2.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BLSM valuation vs. peer median

BLSM compared with the median of 8 peer companies
MetricBLSMPeer medianDifference
Market cap$461.20M$459.66M+0%
Avg. volume193.15K244.41K-21%

Peer median across 8 companies: NGNE, GYRE, ASMB, STTK, RZLT, MNPR, EVO, KMDA.

Valuation

Price and trading

Previous close
14.41
Open
14.34
Day range
13.90 – 15.63
52-week range
11.02 – 27.99
Beta
—
Volume
270.74K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
461.20M
Forward Pe
-3.62
Eps
-10.38
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
27.99
Week52 Low
11.02
Avg Volume
193.15K
Shares Outstanding
31.78M
Ma50
17.27
Ma200
17.60
Earnings Date
Nov 12, 2026
Pct From52w High
-48.16%
Pct From52w Low
31.67%

Related